Prevalence and sociodemographic determinants of uninvestigated dyspepsia in the Czech Republic

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 9, 2008, Pages 898-905

  Rejchrt, Stanislav ^a,d   Koupil, Ilona ^f   Kopáčová, Marcela ^a,d   Voříšek, Viktor ^a,d   Seifert, Bohumil ^a   Pozler, Oldřich ^a,d   Živný, Pavel ^b,c   Douda, Tomáš ^a,d   Palička, Vladiḿir ^b,d   Holčík, Jan ^e   Bureš, Jan ^a,d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Institute of Clinical Biochemistry and Diagnostics   (Czech Republic)

^c ESPCG   (Czech Republic)

^d UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^e MASARYK UNIVERSITY   (Czech Republic)

^f STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Czech Republic; Prevalence; Sociodemographic determinants; Uninvestigated dyspepsia

Indexed keywords

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CZECH REPUBLIC; DEMOGRAPHY; DISEASE ASSOCIATION; DYSPEPSIA; EUROPE; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; SEX DIFFERENCE; SOCIAL ASPECT; SOCIAL CLASS; SOCIOECONOMICS; WIDOW; WIDOWER; AGE; BLOOD PRESSURE; CLINICAL TRIAL; EDUCATIONAL STATUS; EPIDEMIOLOGY; HELICOBACTER PYLORI; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; SMOKING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; DYSPEPSIA; EDUCATIONAL STATUS; EPIDEMIOLOGIC METHODS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SMOKING; SOCIAL CLASS; YOUNG ADULT;

EID: 47049102549     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282fa7508     Document Type: Article

References (51)

1. Dorland's illustrated medical dictionary. 29th ed. Philadelphia: WB Saunders; 2000.
2. Longstreth GF. Approach to the patient with dyspepsia. UpToDate, vol. 15.2. Wellesley, 2007. http://www.uptodate.com.
3. Manning AP, Thompson WG, Heaton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2:653-654.
4. Management of dyspepsia: report of a working party. Lancet 1988; 1: 576-579.
5. Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E,Whitehead WE. The functional gastrointestinal disorders: diagnosis, pathophysiology and treatment: a multinational concensus. McLean: Degnon Assoc; 1994.
6. Jones J, Boorman J, Cann P, Forbes A, Gomborone J, Heaton K, et al. British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. Gut 2000; 47 (Suppl 2):ii1-ii19.
7. Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE, editors. Rome II. The functional gastrointestinal disorders. 2nd ed. McLean: Degnon Assoc; 2000.
8. Talley NJ, Vakil NB, Moayyedi P. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129:1756-1780.
9. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130:1377-1390.
10. Mahadeva S, Goh K-L. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 2006; 12:2661-2666.
11. Maøatka Z. Functional gastrointestinal disorders - 50 years' experience in comparison with the Rome criteria. Folia Gastroenterol Hepatol 2005; 3:10-16. Available at http://www.pro-folia.com.
12. Malagelada JR. The continuing dilemma of dyspepsia. Aliment Pharmacol Ther 2001; 15 (Suppl 1):6-9.
13. Stanghellini V. Pain versus discomfort - is differentiation clinically useful? Aliment Pharmacol Ther 2001; 15:145-149.
14. Chiba N. Treat the patients' main dyspepsia complaint, not the Rome criteria. Am J Gastroenterol 2004; 99:1059-1062.
15. Stanghellini V, Poluzzi E, De Ponti F, De Giorgio R, Barbara G, Corinaldesi R. Idiopathic dyspepsia. Curr Treat Options Gastroenterol 2005; 8:175-183.
16. McQuaid KR. Dyspepsia. In: Feldman M, Friedmann LS, Brandt LJ, editors. Sleisenger & Fordtran's gastrointestinal and liver disease. 8th ed. Philadelphia: Saunders Elsevier; 2006. pp. 121-142.
17. Veldhuyzen van Zanten SJO, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Can Med Assoc J 2000; 162 (12 Suppl):S3-S23.
18. Axon A. Management of uninvestigated dyspepsia: review and commentary. Gut 2002; 50 (Suppl 4):iv51-iv55.
19. Jones RH. Approaches to uninvestigated dyspepsia. Gut 2002; 50 (Suppl 4):iv42-iv46.
20. Population stock and flows in the Czech Republic 2001. Prague: Czech Statistical Office; 2003.
21. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114:555-576.
23. Kopáèová M, Bureš J, Voøí šek V, Konštacký M, Rejchrt S, ivný P, et al. Comparison of different protocols for 13C-urea breath test for the diagnosis of Helicobacter pylori infection in healthy volunteers. Scand J Clin Lab Invest 2005; 65:491-498.
24. StataCorp. Stata reference manual. Release 9.2. College Station, Texas: Stata Press; 2006.
25. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004; 19:643-654.
26. Eggleston A, Farup C, Meier R. The Domestic/International Gastroenterology Surveillance Study (DIGEST): design, subjects and methods. Scand J Gastroenterol 1999; 34 (Suppl 231):9-14.
27. Stanghellini V. International comparative study of the prevalence and impact of gastrointestinal symptoms: an introduction. Scand J Gastroenterol 1999; 34 (Suppl 231):1-2.
28. Koloski NA, Talley N, Huskic S. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003; 17:841-851.
29. Westbrook J, McIntosh J, Talley N. Factors associated with consulting medical or non-medical practitioners: an Australian population-based study. Aliment Pharmacol Ther 2000; 14:1581-1588.
30. Quadri A, Vakil N. Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia. Aliment Pharmacol Ther 2003; 17:835-840.
31. Koloski NA, Talley NJ, Boyce PM. Predictors of health care seeking for irritable bowel syndrome and nonulcer dyspepsia: a critical review of the literature on symptom and psychological factors. Am J Gastroenterol 2001; 96:1340-1349.
32. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, et al. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 2006; 130:1447-1458.
33. Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7:829-833.
34. Thomson AB, Barkun AN, Amstrong D, Chiba N, White RJ, Daniels S, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003; 17:1481-1491.
35. Jones R, Lydeard S. Dyspepsia in the community: a follow-up study. Br J Clin Pract 1992; 46:95-97.
36. Locke GR III, Murray JA, Zinsmeister AR, Melton LJ III, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc 2004; 79:476-482.
37. Ahlawat SK, Cuddihy MT, Locke GR. Gender-related differences in dyspepsia: a qualitative systematic review. Gend Med 2006; 3:31-42.
38. Flier SN, Rose S. Is functional dyspepsia of particular concern in women? A review of gender differences in epidemiology, pathophysiologic mechanisms, clinical presentation, and management. Am J Gastroenterol 2006; 101 (12 Suppl):S644-S653.
39. Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorder. Gastroenterology 2006; 130:1435-1446.
40. Saito YA, Talley NJ, Melton L, Fett S, Zinsmeister AR, Locke GR. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003; 15:687-694.
41. Sperber AD, Shvartzman P, Friger M, Fich A. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol 2007; 19:441-447.
42. Bureš J, Kopáèová M, Koupil I, Voøíšek V, Rejchrt S, Beránek M, et al. Epidemiology of Helicobacter pylori infection in the Czech Republic. Helicobacter 2006; 11:56-65.
43. Moayyedi P, Forman D, Braunholtz D, Feltbower R, Crocombe W, Liptrott M, et al. The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal antiinflammatory drugs. Leeds HELP Study Group. Am J Gastroenterol 2000; 95:1448-1455.
44. Kopáèová M, Bureš J, Koupil I, Rejchrt S, Voøíšek V, Seifert B, et al. Body indices and basic vital signs in Helicobacter pylori positive and negative persons. Eur J Epidemiol 2007; 22:67-75.
45. Talley NJ, Piper DW. A prospective study of social factors and major life stress in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1987; 22:268-272.
46. Talley NJ, Jones M, Piper DW. Psychosocial and childhood factors in essential dyspepsia. Scand J Gastroenterol 1988; 23:341-346.
47. Richter JE. Stress and psychologic and environmental factors in functional dyspepsia. Scand J Gastroenterol 1991; 26 (Suppl 182):40-46.
48. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38:1569-1580.
49. Allescher HD, Adler G, Hartung J, Manns MP, Riemann JF, Wienbeck M., Classen M. Prospective Epidemiologic Study of Epigastric Discomfort (PRESTO). Ground work and preliminary results. Dtsch Med Wochenschr. 1999; 124:443-450 [in German].
50. Wildner-Christensen M, Hansen JM, De Muckadell OB. Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection. Scand J Gastroenterol 2006; 41:149-154.
51. Olmos JA, Pogorelsky V, Tobal F, Marcolongo M, Salis G, Higa R, et al. Uninvestigated dyspepsia in Latin America: a population-based study. Dig Dis Sci 2006; 51:1922-1929.